Related content

A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 87-90

Bentham Science Publishers

Access to resources Recommend Favorite

A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer

By Burmeister Bryan   Walpole Euan   D’Arcy Nancy   Burmeister Elizabeth   Cox Sharon   Thomson Damien   Harvey Jennifer   Smithers B.  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 275-279

Springer Publishing Company

Access to resources Recommend Favorite

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

By Tsavaris Nicolas   Kosmas Christos   Skopelitis Helias   Gouveris Panagiotis   Kopteridis Petros   Loukeris Dioynissis   Sigala Frantzeska   Zorbala-Sypsa Alexandra   Felekouras Evangelos   Papalambros Efstathios  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 369-375

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of oxaliplatin during chronomodulated infusion in metastatic gastrointestinal cancer patients: A pilot investigation with preliminary results

By Merkel Ute   Wedding Ulrich   Roskos Martin   Höffken Klaus   Hoffmann Annemarie  

Experimental and Toxicologic Pathology, Vol. 54, Iss. 5-6, 2003-05 ,pp. : 475-479

Urban & Fischer

Access to resources Recommend Favorite

Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-283

Bentham Science Publishers

Access to resources Recommend Favorite